Roflumilast: first phosphodiesterase 4 inhibitor approved for treatment of COPD

by Mark A Giembycz, Stephen K Field
Published 2010-07-01

Signal transduction and activation of the NADPH oxidase in eosinophils

by Mark A Lindsay, Mark A Giembycz
Published 1997-12-01

A bronchoprotective role for Rgs2 in a murine model of lipopolysaccharide-induced airways inflammation

by Tresa George, Mainak Chakraborty, Mark A. Giembycz, Robert Newton
Published 2018-10-01

Cytokine-induced loss of glucocorticoid function: effect of kinase inhibitors, long-acting β(2)-adrenoceptor [corrected] agonist and glucocorticoid receptor ligands.

by Christopher F Rider, Suharsh Shah, Anna Miller-Larsson, Mark A Giembycz, Robert Newton
Published 2015-01-01

Protective Roles for RGS2 in a Mouse Model of House Dust Mite-Induced Airway Inflammation.

by Tresa George, Matthew Bell, Mainak Chakraborty, David P Siderovski, Mark A Giembycz, Robert Newton
Published 2017-01-01

Glucocorticoid repression of inflammatory gene expression shows differential responsiveness by transactivation- and transrepression-dependent mechanisms.

by Elizabeth M King, Joanna E Chivers, Christopher F Rider, Anne Minnich, Mark A Giembycz, Robert Newton
Published 2013-01-01

Tumour necrosis factor-α regulates human eosinophil apoptosis via ligation of TNF-receptor 1 and balance between NF-κB and AP-1.

by Hannu Kankaanranta, Pinja Ilmarinen, Xianzhi Zhang, Ian M Adcock, Aleksi Lahti, Peter J Barnes, Mark A Giembycz, Mark A Lindsay, Eeva Moilanen
Published 2014-01-01